Ransom Advisory’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$13.1K Buy
+107
New +$13K 0.01% 333
2025
Q1
Sell
-2,572
Closed -$238K 356
2024
Q4
$238K Hold
2,572
0.11% 117
2024
Q3
$216K Hold
2,572
0.1% 115
2024
Q2
$176K Hold
2,572
0.09% 125
2024
Q1
$188K Buy
+2,572
New +$198K 0.1% 117

Other funds holding GILD

Ransom Advisory's GILD Position: Q4 2025 in Review

Ransom Advisory opened a new position in Gilead Sciences (GILD) in Q4 2025: 107 shares worth $13.1K. The stake represents 0.01% of the portfolio and ranks #333 among its holdings. This is a return to the name: Ransom Advisory previously reported a position in GILD as recently as Q4 2024.

Ransom Advisory first reported a position in GILD in Q1 2024 and has held it in 5 quarters since. The position peaked at $238K in Q4 2024. 2,216 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Ransom Advisory held 107 shares of Gilead Sciences worth $13.1K as of Q4 2025.
  • Gilead Sciences was a new Ransom Advisory position in Q4 2025.
  • Gilead Sciences made up 0.01% of Ransom Advisory's portfolio in Q4 2025, its #333 holding.
  • Ransom Advisory first reported a position in Gilead Sciences in Q1 2024 and has held it in 5 quarters since.
  • Ransom Advisory's Gilead Sciences position peaked at $238K in Q4 2024.
  • 2,216 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Ransom Advisory's 13F filing for Q4 2025, filed 6 Jan 2026.